Kovi Levin

Kovi Levin

Auto-generated profile, based on publicly available information

Kovi Levin

Department of Respiratory Medicine, Alfred Health, Melbourne, Australia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2019 in Respirology Case Reports
Verified
Journal Article
Open access
KLKovi Levin
Kovi Levin
CMCatriona McLean
Catriona McLean
RHRyan Hoy
Ryan Hoy
Occupational lung disease secondary to inhalation of silica particles is variable and potentially life‐threatening. As the artificial stone industry has grown over the last two decades, the development of silicosis has been seen to accelerate and behave differently to chronic silicosis. In this case report, we present two patients who underwent lung transplantation for silicosis at the Alfred Hospital, both with predominantly artificial stone masonry exposure. We have identified the presence of both fibrotic/nodular silicosis and conspicuous alveolar proteinosis within the same lung parenchyma of both patients. We then demonstrate the radiological and histopathological correlates of disease; the first time this has been shown clearly in the literature.

1 October 2020 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
HBHayley Barnes
Hayley Barnes
GGGreta Gurry
Greta Gurry
DMDavid McGiffin
David McGiffin
GWGlen Westall
Glen Westall
KLKovi Levin
Kovi Levin
GSGreg Snell
Greg Snell

1 October 2019 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
GSGregory Snell
Gregory Snell
BLBronwyn Levvey
Bronwyn Levvey
MPMiranda Paraskeva
Miranda Paraskeva
HWHelen Whitford
Helen Whitford
KLKovi Levin
Kovi Levin
GWGlen Westall
Glen Westall

22 November 2023 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
GWGlen P. Westall
Glen P. Westall
HBHayley Barnes
Hayley Barnes
KLKovi Levin
Kovi Levin
NGNicole Gaffney
Nicole Gaffney
JHJane Harris
Jane Harris
TWToby Winton-Brown
Toby Winton-Brown

1 November 2019 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
KLKovi Levin
Kovi Levin
BLBronwyn J. Levvey
Bronwyn J. Levvey
MPMiranda Paraskeva
Miranda Paraskeva
HWHelen M. Whitford
Helen M. Whitford
TWTrevor Williams
Trevor Williams
GSGregory I. Snell
Gregory I. Snell

29 January 2025 in Internal Medicine Journal
Verified
Journal Article
Open access
MMMaitri Munsif
Maitri Munsif
MDMatthew Donnan
Matthew Donnan
GSGregory Snell
Gregory Snell
KLKovi Levin
Kovi Levin
MPMiranda Paraskeva
Miranda Paraskeva
Background: Return‐to‐work (RTW) following lung transplant has been associated with increased quality of life, but little is known regarding the rates of and barriers to this in the Australian population.Aims: We aimed to describe, characterise and determine predictors of return to work and social participation in Australian lung transplant recipients. We also sought to explore the relationship between return to work and quality of life.Methods: We conducted a cross‐sectional questionnaire‐based study at the Alfred Hospital, Melbourne between October 2018 and August 2019. The questionnaire evaluated demographics, transplant history, respiratory parameters, employment history and social integration prior to and after lung transplantation.Results: A total of 172 lung transplant recipients were included for analysis. The population was mostly male (56.5%), median age 61 years (interquartile range (IQR) 49.8–67.0) and median time from transplant 4 years (IQR 2–7). A total of 19.2% of patients were working at time of transplant, with 35.5% working after transplant representing an increase in workforce engagement of 84.8% (P < 0.001). A total of 96% of those who returned to work reported an improvement in quality of life. Median time to RTW after transplant was 180 days (IQR 90–360). Multivariable analysis demonstrated an increased rate of RTW in younger recipients (odds ratio (OR) 0.94, 95% confidence interval (CI) 0.89–0.99, adjusted P = 0.029), at greater length of time after transplant (OR 1.09, 95% CI 0.99–1.19, P = 0.084), among those working at the time of transplant (OR 9.55, 95% CI 2.70–33.75, P < 0.001) and with higher socioeconomic status (OR 1.02, 95% CI 1.01–1.04, P = 0.009). Recipients with cystic fibrosis were more likely to RTW (65.8%) than those with other underlying conditions.Conclusions: RTW should be encouraged in lung transplant recipients. Targeted supports and resources aimed at younger recipients may result in greater workforce engagement and overall outcomes after transplant.